Passage Bio Inc. (PASG)
0.50
-0.02 (-3.47%)
At close: Mar 03, 2025, 11:34 AM
Passage Bio Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 3.72M | 3.68M | 1.54M | 800K | 134K | n/a |
| Gross Profit | -3.72M | -3.68M | -1.54M | -800K | -134K | n/a |
| Operating Income | -108.39M | -138.39M | -185.73M | -112.9M | -37.19M | -13.47M |
| Interest Income | 5.6M | 2.27M | 343K | 670K | 696K | n/a |
| Pretax Income | -102.06M | -136.13M | -185.39M | -112.23M | -45.63M | -12.77M |
| Net Income | -102.06M | -136.86M | -191.5M | -111.76M | -54.58M | -12.77M |
| Selling & General & Admin | 41.58M | 49.34M | 60.06M | 30.11M | 6.95M | 928K |
| Research & Development | 61.42M | 86.05M | 117.67M | 81.79M | 29.74M | 9.17M |
| Other Expenses | 5.39M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 108.39M | 135.39M | 177.73M | 111.9M | 36.69M | 10.1M |
| Interest Expense | n/a | 2.27M | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 108.39M | 135.39M | 177.73M | 111.9M | 36.69M | 10.1M |
| Income Tax | n/a | 731K | 6.11M | -470K | 8.95M | -696K |
| Shares Outstanding (Basic) | 54.74M | 54.43M | 53.34M | 38.62M | 45.8M | 23.96M |
| Shares Outstanding (Diluted) | 54.74M | 54.43M | 53.34M | 38.62M | 45.8M | 23.96M |
| EPS (Basic) | -1.86 | -2.51 | -3.59 | -2.89 | -1.19 | -0.53 |
| EPS (Diluted) | -1.86 | -2.51 | -3.59 | -2.89 | -1.19 | -0.53 |
| EBITDA | -98.34M | -138.39M | -185.73M | -112.9M | -36.55M | -12.77M |
| Depreciation & Amortization | 3.72M | 3.68M | 1.54M | 800K | 134K | 10.1M |